Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, reflecting a backend or platform update rather than a change to the clinical trial record information.
    Difference
    0.1%
    Check dated 2026-04-24T05:42:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:36.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added Record History and Study Record Versions with version-by-version details and a compare option, plus related UI elements (Results Posted, Researcher View, Study Details, Download, Save) to improve traceability of the trial record.
    Difference
    39%
    Check dated 2026-03-18T21:58:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added; several history-related sections appear removed or hidden, with updated UI for versioning.
    Difference
    14%
    Check dated 2026-03-11T18:32:52.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new Study Status entry was added on 2026-02-10 and an earlier entry was removed on 2025-11-10 in the record history.
    Difference
    0.2%
    Check dated 2026-03-04T14:37:06.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The new version adds multiple study locations (and their contacts) and removes several previously listed locations. This updates the geographic coverage and contact points shown in the study record.
    Difference
    0.1%
    Check dated 2026-02-25T11:14:46.000Z thumbnail image

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.